Analysis for ON

$73.70 +0.34 (+0.46%)

📈 Growth — 12/30
💰 Profitability — 16/20
🏦 Financial Health — 17/20
💵 Valuation — 12/20
⚠️ Risk — 7/10

Overall Score: 60/100

Summary:

📈 Growth & Financial Trajectory

Over eight quarters, Revenues moved between roughly $1.445B and $1.735B, ending near $1.604B in 2026 Q2, a modest decline from the start. Net income fluctuated, with clear positives in 2025 Q3, 2025 Q4 and 2026 Q2, signaling durable earnings power amid cycles, though some quarters remained negative.

💰 Margins & Cash Flow

Gross margin ranged from about 20% (2024 Q4) to the high 40s in some quarters, averaging in the mid-30s and reflecting favorable mix when demand was strong. Operating cash flow was generally positive across periods, supporting cash generation; net cash flow from continuing activities was also positive in several quarters, while financing and investing cash flows were more volatile.

🛡️ Balance Sheet & Liquidity

Total assets ~$13.4B vs liabilities $6.25B yields a robust equity cushion ($7.24B). The latest Current Ratio (Current assets ~$7.28B vs Current liabilities ~$2.10B) sits around 3.5x, indicating solid liquidity. Long-term debt has varied from ~$3.37B to ~$4.50B, with a balanced debt profile relative to equity.